Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride + Raloxifene in BPH
NCT06944145Phase 2Recruiting
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Dec 2025
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raloxifene in benign prostatic hyperplasia (BPH), sponsored by Beth Israel Deaconess Medical Center. Started Dec 2025; status: recruiting.
02
Drugs
raloxifene
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT06944145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06944145.